首页 | 本学科首页   官方微博 | 高级检索  
检索        

稳心颗粒与普罗帕酮治疗早搏的疗效比较
引用本文:徐红娟,郭燕.稳心颗粒与普罗帕酮治疗早搏的疗效比较[J].中国实验方剂学杂志,2013,19(1):304-307.
作者姓名:徐红娟  郭燕
作者单位:1. 山西中医学院临床学院,太原,030024
2. 太原市中心医院内分泌科,太原,030009
摘    要:目的:比较步长稳心颗粒与普罗帕酮治疗早搏的疗效及临床特点。方法:选择符合入选条件的过早搏动患者共107例(室上性早搏52例、室性早搏55例),完善静息12同步导联心电图,随机分为稳心颗粒组(W组,n=62)、普罗帕酮组(P组,n=45),W组给予稳心颗粒9 g,3次/d,口服;P组给予普罗帕酮150 mg,3次/d,口服。4周后,复查12导联同步心电图和24 h动态心电图,比较治疗前后早搏减少百分率、24 h平均心率、最慢心率及校正的QT间期离散度(QTcd)。结果:稳心颗粒治疗室上性早搏、室性早搏的有效率分别为73.53%,78.57%,总有效率75.81%,与普罗帕酮比较无统计学差异。稳心颗粒组治疗前后24 h平均心率降低不明显(77.67±5.86)bpm vs(77.42±4.99)bpm]、最慢心率降低不明显(60.89±5.40)bpm vs(60.55±4.71)bpm];普罗帕酮组治疗前后24 h平均心率明显降低(78.51±5.42)bpm vs(76.96±5.57)bpm,P<0.05]、最慢心率明显降低(61.31±5.69)bpm vs(58.53±4.80)bpm,P<0.05]。稳心颗粒能改善糖尿病、冠心病的QTcd。结论:步长稳心颗粒能有效减少早搏,不减慢治疗前后的24 h平均心率及最慢心率,能减小糖尿病、冠心病的QT离散度,适合心率较慢、糖尿病、冠心病患者合并早搏的治疗。

关 键 词:稳心颗粒  普罗帕酮  过早搏动  24h平均心率  最慢心率  QT离散度
收稿时间:8/8/2012 12:00:00 AM

Comparison of Efficacy in Treatment of Premature Beat between Buchang Wenxin Granule and Propafenone
XU Hong-juan and GUO Yan.Comparison of Efficacy in Treatment of Premature Beat between Buchang Wenxin Granule and Propafenone[J].China Journal of Experimental Traditional Medical Formulae,2013,19(1):304-307.
Authors:XU Hong-juan and GUO Yan
Institution:Shanxi University of Traditional Chinese Medicine, Taiyuan 030024, China;Dept of Endocrinology, Taiyuan Municipal Central Hospital Taiyuan 030009, China
Abstract:Objective: To compare the efficacy and clinical features of Buchang Wenxin granule and propafenone in the treatment of premature beat. Method: One hundred and seven patients with premature beats (supraventricular SV, n=52;ventricular V, n=55)randomly were divided into Wenxin granule group(W group, n=62)and propafenone group(P group, n=45),the patients in W group were given Buchang Wenxin Granule 9 g·d-1, 3/d, the patients inP group were given propafenone 150 mg·d-1, 3/d. 4 weeks later, all patients were evaluated by 12-lead simultaneous body surface electrocardiogram and 24 hours ambulatory Holter, respectively compares the percentage of reduced premature beat, 24 h average heart rate, the slowest heart rate, QTcd before and after treatment. Result: Wenxin Granule in therapeutic SV,V are respectively 73.53% and 78.57%, the total efficiency is 75.81%, have no significantly difference compared with propafenone; the 24 h average heart rate and the slowest heart rate of W group had not decreased significantly before and after treatment(77.67±5.86) bpm vs (77.42±4.99) bpm, (60.89±5.40) bpm vs (60.55±4.71) bpm; while P group had decreased significantly before and after treatment(78.51±5.42) bpm vs (76.96±5.57) bpm (P<0.05),(61.31±5.69) bpm vs (58.53±4.80) bpm (P<0.05). Wenxin rranule also can reduce the QTcd of patients with Diabetes mellitus(DM) and coronary heart disease(CHD). Conclusion: Buchang Wenxin granule is effective for treating premature beats, suitable for the patients with slower heart rate,DM,CHD.
Keywords:Buchang Wenxin granule  propafenone  premature beats  24 h average heat rate  the slowest heart rate  QT interval dispersion
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号